Our Company
Culture & Values
Leadership
Global Locations
Corporate Compliance
Subsidiaries & Joint Ventures
Diversity & Inclusion
20th Anniversary
Tigermed EMEA
Medicinal Chemistry
Compound Screening
DMPK
Safety & Toxicology
Bioanalytical
CMC
Medical Writing
Clinical Monitoring
Regulatory Affairs
Data Management and Statistical Analysis
Clinical Development Strategy
Decentralized Clinical Trials (DCTs)
Site Management (SMO)
Medical Device / IVD
Multi-region Clinical Trial (MRCT)
Vaccine Clinical Trial
Tigermed Insight
Top Global CRO Companies: List & How to Compare Them (2026 Updated)
Sep 22, 2026
A global contract research organization (CRO) provides outsourced clinical development services for pharmaceutical, biotechnology, and medical device companies. Operating across multiple international jurisdictions, global CROs coordinate complex multi-regional clinical trials (MRCTs), manage cross-border regulatory submissions, harmonize global laboratory and data flows, and align multinational clinical trial sites.
When comparing top global CRO companies, sponsors typically evaluate geographic coverage, therapeutic expertise, regulatory capabilities across key regions (such as the US, Europe, and Asia-Pacific), technology adoption, and cross-regional delivery consistency.

Founded in 2004, Tigermed is a reliable global contract research organization (CRO), with its Global Headquarters in Hangzhou and International Headquarters in Hong Kong. We provide comprehensive clinical development services for multinational biopharmaceutical and medical device companies. With operations across 43 countries and more than 180 service locations worldwide, we support clients in advancing clinical development programs across markets.
Drawing on global project-delivery capabilities and deep operational experience in China and the broader Asia-Pacific region, Tigermed helps sponsors coordinate cross-regional clinical development programs. According to Frost & Sullivan, Tigermed held a 10.9% share of China’s clinical CRO market in 2025 and was the only Chinese clinical CRO ranked among the global Top 10.
Tigermed provides research and development support throughout the product life cycle, spanning preclinical research, laboratory services, clinical development, regulatory affairs, and post-marketing services. The company also continues to strengthen its digital capabilities in areas such as artificial intelligence (AI) and decentralized clinical trials (DCTs), with the aim of improving coordination and execution in clinical research.
IQVIA was formed through the merger of Quintiles and IMS Health in 2016 and adopted the IQVIA name in 2017. Headquartered in Durham, North Carolina, IQVIA provides clinical research services, healthcare data, technology, and analytics solutions for the life sciences industry.
Its offerings include clinical development, patient recruitment, real-world evidence, and technology-enabled research services. IQVIA is frequently included in global CRO comparisons because of its international scale and its combination of clinical research, data, and technology capabilities.
Founded in 1990 and headquartered in Dublin, Ireland, ICON is a global provider of outsourced clinical research and development services.
ICON supports clinical trials from Phase I through Phase IV, as well as medical affairs and other development-related activities. The company expanded its clinical research capabilities through its acquisition of PRA Health Sciences, completed in 2021.
Through operations across multiple countries, ICON provides global clinical development and trial management services to pharmaceutical, biotechnology, and medical device sponsors.
Founded in 1982, Parexel is a global clinical research organization and biopharmaceutical services company providing Phase I–IV clinical development services.
Its services include clinical development, clinical trial management, regulatory and consulting support, medical writing, and patient-focused clinical research solutions. Parexel’s global footprint and clinical, regulatory, and therapeutic expertise make it a commonly reviewed company in global CRO comparisons.
Syneos Health was formed in 2018 through the merger of INC Research and inVentiv Health. It is a fully integrated biopharmaceutical solutions organization providing clinical development and commercialization services.
Its clinical capabilities include clinical trial management, site support, and operational solutions, while its commercial services extend to commercialization and marketing activities. Syneos Health serves pharmaceutical and biotechnology companies through global clinical and commercial operations.
Syneos Health became a privately held company following the completion of its acquisition by a private-investment consortium in 2023. Its corporate headquarters is in Morrisville, North Carolina.
PPD was founded in 1985 and became part of Thermo Fisher Scientific in 2021. It operates as part of Thermo Fisher Scientific’s clinical research services business.
Thermo Fisher Scientific provides clinical trial services, laboratory services, and scientific support for pharmaceutical and biotechnology companies. Its combined clinical research and laboratory capabilities support integrated drug-development programs.
Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace is a full-service clinical research organization serving pharmaceutical, biotechnology, and medical device companies.
The company provides clinical trial management, regulatory support, medical monitoring, and related development services across multiple therapeutic areas.
Founded in 1986, Worldwide Clinical Trials is a full-service global contract research organization (CRO) that partners with biotechnology and pharmaceutical companies to support clinical development programs.
Its capabilities include bioanalytical laboratory services, Phase I–IV clinical trials, post-approval studies, and real-world evidence research. The company’s therapeutic focus includes neuroscience, oncology, rare diseases, and cardiometabolic and inflammatory diseases. Worldwide’s corporate headquarters is located in Research Triangle Park, North Carolina.
Fortrea became an independent contract research organization (CRO) in 2023 following the spin-off of Labcorp’s Clinical Development and Commercialization Services business. Before the separation, this business operated under Labcorp and associated brands, including Labcorp Drug Development and Covance.
Headquartered in Durham, North Carolina, Fortrea provides global clinical development services for the life sciences industry. Its core offerings include Phase I–IV clinical trial management, clinical pharmacology, consulting services, technology-enabled trial solutions, and post-approval services.
Fortrea has more than 30 years of clinical development experience and operates as the independent CRO successor to Labcorp’s former clinical development and commercialization business.
When evaluating the top 10 contract research organizations, companies can consider several factors:
|
Evaluation Area |
Key Questions |
|---|---|
|
Geographic Coverage |
Can the CRO support clinical trials in required countries and regions? --------------------------------------------------------------------------- |
|
Clinical Experience |
Does the CRO have relevant therapeutic and trial phase experience? --------------------------------------------------------------------------- |
|
Regulatory Capability |
Can the CRO support local regulatory requirements and submissions? --------------------------------------------------------------------------- |
|
Technology Capability |
Does the CRO provide AI, digital platforms, or DCT solutions? --------------------------------------------------------------------------- |
|
Service Integration |
Can the CRO support multiple stages of clinical development? --------------------------------------------------------------------------- |
The most suitable CRO depends on project objectives, geographic requirements, regulatory considerations, and internal resources.
The global CRO market includes multinational organizations and specialized providers with different service models. For sponsors planning international clinical development programs, comparing CRO capabilities based on regional experience, service scope, technology adoption, and operational expertise can help identify suitable partners.
Ready to advance your clinical development program in China and beyond? Contact Tigermed to discuss how our global CRO capabilities, local expertise, and integrated solutions can support your research goals.
The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.
Please complete the form below to submit your request or questions. Our representative will respond promptly.